Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

2 terminated out of 46 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

0%

0 of 22 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (19)
P 2 (2)
P 3 (3)
P 4 (4)

Trial Status

Completed22
Unknown11
Recruiting8
Not Yet Recruiting2
Terminated2
Enrolling By Invitation1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (46)

Showing 20 of 20 trials
NCT06486467Not ApplicableRecruiting

Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI

NCT07157748Not ApplicableNot Yet RecruitingPrimary

Effects of Compound Ejiao Syrup on Exercise Tolerance and Quality of Life in Critically Ill Patients After ICU Discharge: A Double-Blind, Multicenter,Randomized Controlled Clinical Study

NCT07124442RecruitingPrimary

Disease Severity, Mortality Risk, and Muscle Function in Intensive Care Unit Patients

NCT07108179Enrolling By InvitationPrimary

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

NCT07025941Not ApplicableCompletedPrimary

Impact of Comprehensive Rehabilitation Nursing Combined With Refined Airway Management and Nutritional Support on Prognosis and Care Delivery Models in Critically Ill Patients

NCT06580704Not ApplicableCompleted

Lumbosacral Erector Spinae Plane Block Versus Psoas Muscle Compartment With Sciatic Nerve Block for Anesthesia for Unilateral Lower Limb Operations in Critically Ill Patients

NCT06109142RecruitingPrimary

Clearance of Vasoactive Metabolites With Blood Purification

NCT06543602RecruitingPrimary

the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave

NCT03529617Recruiting

Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates

NCT04045366RecruitingPrimary

Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients

NCT05790915CompletedPrimary

Impact of Interventions on Admission SOFA Score on Clinical Outcomes of Critically Ill Patients

NCT04924920Not ApplicableRecruitingPrimary

Sigh35 and End-expiratory Occlusion Test (EEOT) for Assessing flUid Responsiveness in Critically Ill Patients Undergoing Pressure Support Ventilation

NCT06234787Recruiting

Continuous Subcutaneous Glucose Monitoring in Critical Patients

NCT06227702Not ApplicableNot Yet RecruitingPrimary

Vexus-guided Fluid Management in Patients With Septic Shock After the Resuscitation Phase

NCT06049979UnknownPrimary

Correlation Between Intestinal Blood Flow and Intestinal Dysfunction in Critically Ill Patients

NCT05464979Phase 4UnknownPrimary

Esketamine Induction Intubation in ICU Patients.

NCT05564975Unknown

Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients

NCT05458687Not ApplicableUnknownPrimary

Traditional Chinese Medicine for Complications in Critically Ill Patients

NCT04793568Phase 2UnknownPrimary

Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study

NCT05132751Not ApplicableUnknown

Machine Learning Ventilator Decision System VS. Standard Controlled Ventilation

Scroll to load more

Research Network

Activity Timeline